chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fainting shortly after receiving vaccination. Patient stated he usually faints at the sight of blood. Patient fell and hit his hip but was not injured during the event. He came to and was okay after. Patient stayed seated in the store for about 20 to 30 minutes after fainting event.
Slightly sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Slightly sore left arm) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0A50C21 and 022B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Slightly sore left arm). At the time of the report, VACCINATION SITE PAIN (Slightly sore left arm) outcome was unknown.            No concomitant medication information provided by the reporter.  No treatment information provided.
I was first nauseous which was expected but ran a fever of 105 and continued to run a fever of 103 up until Thursday when I went to ER for intense swelling in my arm and a hard knot. I went to dr who advised I was having an allergic reaction and told me to take benedryl I had a 2in by 2inch hive under my skin at my time of visit which had gone down a little because of benedryl and it was extremely painful even 9 days out. I experienced extreme confusion and mental fog from Sunday all the way to Wednesday where I felt confused, and was having some rapid breathing.
pt recv vax & 2hr p/vax pt noticed swelling & redness;did not notify clinic until 10OCT97;next day pt felt nausea, sore arm, redness;no other sx;noticed bruise @ site;
pt recvd vax & had S.O.B; mild wheeze; throat tight & sensation of closing; to er, given epi; dph; steroids & other meds;
No side effects reported.; HCP calling to report an expired dose of PEDVAX HIB was given to a patient. No side effects reported. HCP reports the vaccine has not had any temperature excursions. No additional information provided. Additional AE case filed, refer to case #0244910; This spontaneous report was received from Other Health Professional and refers to a 3-year-old patient of unknown gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 03-AUG-2023, the patient started therapy with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 0.5 ml, lot #T037651, expiration date: 20-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided).  On 03-AUG-2023, HCP called to report an expired dose of PEDVAX HIB was given to a patient. No side effects reported. HCP reports the vaccine has not had any temperature excursions.No additional information provided. Additional AE case filed, refer to case #0244910. No PQC.
Information has been received via Schering-Plough Research Institute and assigned manufacturer number 2007SP003351, from a mother concerning her 27 year old son who was vaccinated with RECOMBIVAX HB. Subsequently the patient experienced a year long coughing reaction. The patient's outcome was not reported. No further information is available.
This case was reported by a consumer and described the occurrence of pain in arm in a female patient who received FLUARIX QUADRIVALENT 2018-2019 season (batch number Y53NN, expiry date 30th June 2019) for prophylaxis. On 26th October 2018, the patient received FLUARIX QUADRIVALENT 2018-2019 season. On 26th October 2018, immediately after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced pain in arm and shoulder pain. On an unknown date, the patient experienced injected limb mobility decreased and activities of daily living impaired. On an unknown date, the outcome of the pain in arm, shoulder pain, injected limb mobility decreased and activities of daily living impaired were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, shoulder pain, injected limb mobility decreased and activities of daily living impaired to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional details were provided as follows: This case was reported by a pharmacy via a pharmacy claims management company. The age at vaccination was not reported. The patient experienced pain immediately after receiving the FLUARIX. At the time of reporting, it has been several months and the pain has not gone away in her left shoulder and arm. Less than year after receiving FLUARIX, it was hard to lift arm or perform daily tasks. The patient had sought medical treatment because of these events.
Erythema of about 10-12 cm in size, increased local temperature, indurated and tender around injection site over right thigh.
This spontaneous report as received from a nurse practitioner refers to a 10 months old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 22-JAN-2015, the patient was vaccinated with the dose of LIQUID PEDVAXHIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had a temperature excursion. No information on patient's concomitant medication was provided. No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
On 07/30/2022 I started having a fever, body aches, and loss of taste and smell. I went to the doctor and got tested for COVID-19 on 07/31/22 and it came back positive. I took Ibuprofen and Tylenol. The symptoms lasted for 3 days.
Rash - BENADRYL 25 mg/10 ml (25 mg)
Case number PHEH2013US021327, is an initial spontaneous report received from the medical assistant on 10 OCT 2013 and a follow up report from the medical assistant received on 09 DEC 2013. This case refers to an 11 years old male patient. Past medical history was not reported. Concomitant vaccines included Tdap (other manufacturer, batch  number: AC52B076BA) and GARDASIL (other manufacturer and batch number: H621608) on 03 SEP 2013. He was vaccinated with MENVEO (batch number: M11081 and expiry date: 30 APR 2014), at a dose of 0.5 ml in the right arm intramuscularly on 04 SEP 2013, which had temperature excursion below 2 degree Celsius. Reporter stated that, she does not know if the vaccine was frozen. No adverse event was reported following this administration error.  Follow up report  from the medical assistant received on 09 DEC 2013. The site of vaccination and concomitant vaccines were added.
confused; More than 35 days between first and second dose; This spontaneous case was reported by a patient and describes the occurrence of CONFUSIONAL STATE (confused) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between first and second dose) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Concurrent medical conditions included Handicap ((Disabled Veteran)).   On 12-Jul-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 23-Feb-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between first and second dose). On an unknown date, the patient experienced CONFUSIONAL STATE (confused). At the time of the report, CONFUSIONAL STATE (confused) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between first and second dose) outcome was unknown.            No concomitant product was provided by the reporter. No treatment medication was provided.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Additional Details: PATIENT FAINTED AFTER RECEIVING VACCINE AND INJURED THEIR CHIN, PATIENT WAS SITTING DOWN AND WAS ABLE TO FEEL BETTER AFTER GIVEN WATER AND REST ON BENCH
pressure in head causes pain; light sensitivity; pressure in head causes pain; issues walking; usual tactics at play here using fear; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced headache (Verbatim: pressure in head causes pain), photosensitivity (Verbatim: light sensitivity), head pressure (Verbatim: pressure in head causes pain), walking difficulty (Verbatim: issues walking) and fear (Verbatim: usual tactics at play here using fear). The outcome of the headache, photosensitivity, head pressure, walking difficulty and fear were not reported.   The reporter considered the headache, photosensitivity, head pressure, walking difficulty and fear to be possibly related to Bexsero and Bexsero Pre-Filled Syringe Device.     The company considered the headache, photosensitivity, head pressure, walking difficulty and fear to be possibly related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 17-Jul-2023 The case was received from the patient's parent via interactive digital media. The reporter stated that ridiculous big pharma push.  The patient developed so many complications from this exact vax. The patient usual tactics at play using fear. This would be a huge unfollow from the reporter and please wake up and research what was exactly in the vaccines. Seriously, then, please look at the number of shots children these days receive and compare it to the autism, food allergy and cancer cases. The reporter bet that they would not be pushing this anymore or wait- might be for the right amount of money they will. The follow-up could not be possible as no contact details were available.
patient became itchy all over approximately 15 minutes after shot administered gave her a 50mg dose of benadryl pt reported feeling much better 1 hour later
pt recv vax 23JUL96 & 10 days post vax pt exp blurry vision which lasted 1hr & then resolved;sx was followed by a severe h/a & nausea;
Upset stomach; Muscle ache/ aches; Joint ache; Low grade fever; Chills; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Upset stomach), MYALGIA (Muscle ache/ aches), ARTHRALGIA (Joint ache), PYREXIA (Low grade fever) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033F21A, 0Z9LZ0A and 030MZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  No medical history was provided by the reporter. Concomitant products included FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY) for an unknown indication. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Upset stomach), MYALGIA (Muscle ache/ aches), ARTHRALGIA (Joint ache), PYREXIA (Low grade fever), CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and DIMENHYDRINATE (DRAMAMINE) for Adverse event, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Upset stomach) and HEADACHE (Headache) outcome was unknown and MYALGIA (Muscle ache/ aches), ARTHRALGIA (Joint ache), PYREXIA (Low grade fever), CHILLS (Chills) and NAUSEA (Nausea) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was linked to MOD-2021-023646 (Patient Link).
Left deltoid erythema, warmth, induration & bruising over 48 hrs - ice & ibuprofen.
Patient states pain, swelling, hot to touch around area of injection. Tx BENADRYL as needed.
Bruising, which is typical for me Exactly 10 days post vaccination, on 03/18/2021 I developed swelling, rash and itching at injection site Uncomfortable, but not miserable Treating w/topical Benadryl during day and oral Benadryl at night
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2015, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. In 2016, the patient was treated by a physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Additional information has been requested.
TOOK TWO DOSES IN A ROW; This spontaneous case (PVX2019-1465) was received from a pharmacist on 06-Jun-2019. It describes a 15-year-old female consumer who "took two doses in a row", while being on Vivotif for an unknown indication.  Case report: The consumer took two doses in a row. The doses were taken on 05-Jun-2019 and 06-Jun-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
Very painful at night, unable to bring hand behind back. Saw an Orthopedic and was put on Prednisone.
In July 2021 I didn't have a fever, but I had experienced chills. I had pain in both of my shoulders, knees, and groin area. At the end of July 2021 I went to the doctors office. They did some test on me. The doctor saw that my iron level was low so I was prescribed ferrous sulfate 325mg 2xday, but now I take it 1xday. I have been going to physical therapy for my knees and shoulders.
Patient received Covid vaccines and came to ED with worsening dyspnea and bilateral pneumonia.  Patient is admitted with Covid pneumonia and respiratory failure with hypoxia.
Injection site and surrounding 3 inches of skin became hot, red, and swollen 24 hours after injection. Swelling increased for 12 hours and decreased over the course of 7 days. Site is still noticeably pinker now (3 weeks after injection)
I was on break at work and I went to a friends house. I was sitting on the bed and ended up blacking out and having a full blown seizure. I do not remember anything from it. I don't remember feeling weird. I woke up to my friend grabbing my shoulders and asking if I was okay. I ended up biting my tongue really bad and my body was hurting really bad the next few days. I went to the doctor the following day and I am seeing neurologist now.
Experienced swelling, burning, and slight itching at the injection spot; Experienced swelling, burning, and slight itching at the injection spot; Experienced swelling, burning, and slight itching at the injection spot; A spontaneous report was received from a consumer, concerning herself, a 64-year-old female patient, who received Moderna's COVID-19 vaccine and experienced swelling, burning, and itching at the injection spot.  The patient's medical history was not provided. Concomitant product use was not provided.  On 23-Dec-2020, approximately seven days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot number 025J20-2A) intramuscularly in the upper left arm for prophylaxis of COVID-19 infection.   On 30-Dec-2020, 7 days after the shot of vaccine, the patient experienced swelling, burning and slight itching at the injection spot (not too bad). Hence, she was treated with ibuprofen and the first dose of which helped patient 50% and the second dose provided full relief from the symptoms. These event had lasted for two days.   Action taken with mRNA-1273 in response to the events were not reported.   The outcome of the events, experienced swelling, burning and itching at the injection spot was resolved on 01-Jan-2021.; Reporter's Comments: This case concerns a 64 year old, female patient, who experienced a non-serious expected event of injection site pruritus, injection site pain, and injection site swelling. The events occurred 8 days after first dose of mRNA-1273, lot # 039K20A. Treatment included Advil. Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded.
Extremely vivid dreams that starting about 1 week after the second shot and continued until about 2 weeks after the second shot. Dreams stopped 2 week after the second shot.
Information has been received from a physician concerning a 6 year old patient who on 03-AUG-1993, 15-SEP-1993 and 27-SEP-1999, was vaccinated with the first, second and third dose of RECOMBIVAX HB (manufacturer unknown) (routes, expiration dates and lot numbers not reported). The physician reported that the patient received the three doses of RECOMBIVAX HB (manufacturer unknown), but still did not show immunity to hepatitis B. It was noted that the physician did not know certainly which vaccine for Hepatitis B was given to the patient since this was given in another office. The patient sought medical attention called to the office. At the time of the report the patient's outcome was unknown. Additional information has been requested.
Shortness of breath, and could not catch breath and felt like there was fluid in lungs, night sweats, no fever IV Drip, Breathing treatments X2 6/23 Prednisone, Course of Antibiotics(5-day), and later was prescribed Zithromax and Albuterol for nebulizer
Patient  received her 1st Pfizer vaccine dose on 7/23/21 and was scheduled to 21 days later to receive her 2nd dose on  8/13/21. Patient and her parent reported the vaccine clinic to receive her 2nd dose on 8/4/2021; 12 days after her 1st dose.
Itching in the groin, entire back, throat and mouth 1 hour after receiving the vaccine, pt self administered an epipen and followed up with primary care dr.
8 days after shot, left arm (arm that received the injection) started swelling below the injection site, developed a red, itchy rash that was oval shaped and approximately 6" x 4". 24 hours later, the swelling went down and the itchiness abated but the redness is still visible as of today.
Swelling, Burning, Itching, Warm to the touch, Pain when it's touched or any pressure get put onto it, redness at a big size on my arm.
Hives on neck and face on day of vaccine (2-24-2021) two days later(2-26-2021)  gotred rash on left arm with hard lump and lump under armpit,headache(2-28-2021) lump under armpit and lft arm had pain with touch.  I took Alive,tylenol,benadryl.  Today 3/5/2021  Still have lump under armpit and left arm but has went down on side i still have headache.
Moderna Dose 1 7/6/21 (038C21A) Moderna Dose 2 8/3/21 (021C21A) COVID Positive 1/25/22  1/25/22: Patient is 61-year-old female past medical history significant for back pain, hypothyroidism with no recent follow-up with PCP was brought by EMS after she was found on the ground by bystanders. Patient is poor historian and history obtained from the ED provider patient apparently fell next to her car and crawled back to her house where she was found by bystanders   Patient stated that she experienced in the past multiple falls this time fell on the ice and feels pain on her knees bilaterally.  Patient stated lives alone and had also fell from the bed few days back  Patient stated that she has not seen her PCP for long time   In the emergency department patient was noted to be hypoxic sign 6% and required oxygen supplementation 8 LPM via face mask.  Lab was significant for elevated sodium of 146, creatinine of 1.77, lactic acid of 2.9, troponin of 0.05.  ABG noted to to be acidotic with hypoxia.  White cell count was elevated 10 point a 3 without any left shift; hemoglobin 9.5.  Urinalysis was remarkable for infection; D-dimer elevated 2.1 1 and V/Q scan pending  1/29/22: Patient is a 61-year-old female past medical history significant for back pain, hypothyroidism with no recent follow-up with PCP was brought by EMS after she was found on the ground by bystanders.  Patient admitted for acute encephalopathy and COVID-19 pneumonia. Initial CVA work was negative. Patient was noted to have very high TSH and low T4 so was started on IV Synthroid for possible myxedema coma.  Patient's symptom was improving. Patient was also being treated for acute hypoxic respiratory failure secondary to severe COVID pneumonia on 15 L facemask.  Patient was receiving antibiotics, remdesivir and was started on Barictinib.  Patient's mentation and symptom was improving.  On 01/29/2022 patient started having acute left-sided weakness, aphasic speech and right-sided facial droop. NIH 17. Stroke alert was called.  Stat CT head and CT angio ordered.  Neurology has been consulted.  CT head negative.  CT angio of the head below.  Patient was transferred to the ED for evaluation of tPA. Case was discussed with the stroke team at local facility who recommended no tPA and transferring patient to alternate local facility for further evaluation
persistent rash: gets raised when hot & sweaty, otherwise is just itchy;no problems during series;no other sx;26SEP95 f/u from MD impression:urticaria vs possible variant of hot tub folliculitis;plan: atarax, Triamcinolone prednisone tape
Lower abdominal pain and lower back pain. My whole left side was painful to the touch, slight nausea for three days. Felt like I had bladder infection and yeast infection all in one. Had a hard time standing up. Has resolved now. 101.4 fever. my teeth were sensitive and sinuses hurt really bad. 01/05/2020 first vaccine.
Felt Tired; Felt Achy; A spontaneous report was received from a Consumer concerning a 80-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tiredness and felt achy The patient's medical history was not provided. No relevant concomitant medications were reported. On 15 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Not provided) intramuscularly in the left arm for prophylaxis of COVID-19 infection.The patient has received her first dose of mRNA-1273 on 18 Jan 2021. On 15 Feb 2021, the patient felt tired and achy.No laboratory details was provided.Treatment details was not provided  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, fatigue and pain was considered as resolved on 17 Feb 2021.